BAP Council Member Details
Professor Carmine Pariante
Institute of Psychiatry
Council Member until 2018
I can honestly say that my academic career would have not been the same without the support of the BAP – both as an Association and as an ensemble of colleagues who would look after each other – and I believe in giving back, as a Council Member. Indeed I was already a Council Member in the past, and I have continued to participate to BAP teaching activities over the years. Now I want to re-enter the Council so that I can help pushing forward the initiatives required to support our field – especially at this time of financial uncertainties, with both public and private funding shrinking.
I have always been interested in the brain, both as a medical student and as psychiatry trainee. Before coming to London, I spent about three years in the Unites States (in Atlanta), where I learned how to work in a psychopharmacology laboratory. I then started my academic career at the Institute of Psychiatry in 1999, as a Research Fellow and Lecturer, and I have been at the Institute since.
I am a loyal and enthusiastic member of the BAP. I first attended the BAP conference when I was working with the late Rob Kerwin, who has been one of the most important figures in the Association, and who so prematurely left us a few years ago. I have attended the conference every year, except the year that I got married, because the dates clashed! Many of you will have seen me every year on the dance floor, at the Tuesday night disco after the Gala Dinner. I have been honoured to receive both the junior (in 2002) and the senior (in 2009) psychopharmacology award from the Association, and over the years I have built friendships with many fellow scientists who, like me, are part of the BAP family. As a Council Member, I will make the best use of my skills to advance psychopharmacology at all levels: research, education, and public engagement. Through this, I hope I will also be able to help the wider community of patients that are today waiting for the new medications.
Declaration of Interests
- Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
- Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
- Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
- Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
- Consultant to Eleusis Benefit Corporation and to Johnson & Johnson. The income was paid into a University account and used to support research
- Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
- Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
- - Research funding from Johnson & Johnson for research on depression and inflammation
- Research funding from Wellcome/MRC Consortia that include GSK, Johnson & Johnson, Lundbeck and Pfizer
- Have you, in the past three years, had membership of the speakers' bureau for any company?
- One talk, by Lundbeck
- Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
- Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
- Have you, in the past three years, recruited patients for industry-sponsored studies?
- If there is anything else you feel it necessary to disclose, please provide details.
- Around 10% of the funding supporting Professor Pariante’s research comes from pharmaceutical companies interested in the development of new antidepressants; the remaining 90% comes from the UK Medical Research Council, the NHS, the European Commission and research charities
Form completed on 27th April 2018